½ÃÀ庸°í¼­
»óǰÄÚµå
1447740

½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀå Æò°¡ : Á¦Ç°, ¼ö¼ú À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ±âȸ ¹× ¿¹Ãø(2017-2031³â)

Stoma/Ostomy Care Market Assessment, By Product, By Surgery Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Markets & Data | ÆäÀÌÁö Á¤º¸: ¿µ¹® 232 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°è ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀå ±Ô¸ð´Â 2023³â 34¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2024³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 4.76%ÀÇ CAGR·Î 2031³â¿¡´Â 49¾ï 5,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå È®´ë´Â ½ÅÁ¦Ç° Ãâ½Ã, Àå·ç±â±¸ÀÇ ¹ßÀü, ´ë»ó ȯÀÚ Àα¸ÀÇ Áõ°¡, Àü ¼¼°è ¿©·¯ Áö¿ª¿¡¼­ ȯÀÚ ±³À° Ä·ÆäÀÎÀÇ Áõ°¡¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. °í·É Àα¸ÀÇ Áõ°¡´Â ½ºÅ丶/¿À½ºÅä¹Ì Äɾî Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù.

¿°Áõ¼º Àå ÁúȯÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. J Clin Med¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é 2006³â Àα¸ 10¸¸ ¸í´ç 200¸íÀ̾ú´ø ¿°Áõ¼º ÀåÁúȯ À¯º´·üÀº 2021³â¿¡´Â Àα¸ 10¸¸ ¸í´ç 321.2¸íÀ¸·Î 46% ÀÌ»ó Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, ¿À½ºÅä¹Ì ÄÉ¾î ¹é ¹× ¿À½ºÅä¹Ì ÄÉ¾î ºÎ¼Óǰ °³¹ßÀÇ ±â¼ú °­È­·Î ÀÎÇØ µðÀÚÀÎÀûÀ¸·Î È¿°úÀûÀÎ ¾×¼¼¼­¸® ¹× ´©Ãâ ¹æÁö ÆÄ¿ìÄ¡ Á¦Ç° °³¹ß µî Àå·ç °ü¸® °¡¹æ ¹× Àå·ç °ü¸® ¾×¼¼¼­¸®ÀÇ °³¹ßÀÌ °­È­µÇ¸é¼­ ½ÃÀå ¼ºÀåÀÌ ´õ¿í ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. °¨¿°, ºÎ»ó, ´ëÀå¾ÏÀ» Æ÷ÇÔÇÑ ¸¸¼ºÀûÀÎ °Ç°­ ¹®Á¦´Â ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀåÀÇ ¼ö¿ä¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù.

½ºÅ丶 Äɾî Á¦Ç°¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óµµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿©·¯ E-Commerce Ç÷§Æû°ú ÆòÆÇÀÌ ÁÁÀº ¿Â¶óÀÎ ¾à±¹Àº Àå·çÀÇ È¿°úÀûÀÎ °ü¸®¿¡ ÇʼöÀûÀÎ Á¦Ç° ¹× ¾×¼¼¼­¸®¸¦ ÆÇ¸ÅÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº °í°´¿¡°Ô À¯¸®ÇÑ ÇÒÀÎ ÇýÅÃÀ» Á¦°øÇϸ鼭 Á¦Ç°ÀÇ ½Å¼ÓÇÑ ¹è¼ÛÀ» º¸ÀåÇÕ´Ï´Ù.

´ëÀå¾ÏÀÇ À¯º´·ü Áõ°¡

Àü ¼¼°è ¿©·¯ Áö¿ª¿¡¼­ ´ëÀå¾Ï ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹¾ÏÇùȸ(American Cancer Society)¿¡ µû¸£¸é, 2024³â ¹Ì±¹¿¡¼­ »õ·Î ¹ß»ýÇÏ´Â °áÀå¾Ï ÃßÁ¤ ȯÀÚ ¼ö´Â ³²¼º 54,210¸í, ¿©¼º 52,380¸í, Á÷Àå¾Ï ÃßÁ¤ ȯÀÚ ¼ö´Â ³²¼º 27,330¸í, ¿©¼º 18,890¸íÀÔ´Ï´Ù. ´ëÀå¾ÏÀÇ Áõ°¡·Î ½ºÅ丶/¿À½ºÅä¹Ì ÄɾîÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ º´»ó¿¡ ´©¿ö Àִ ȯÀÚ¿¡¼­ ±× Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ´ëºÎºÐÀÇ °æ¿ì ȯÀÚ´Â ¼ö¼ú ÈÄ È¸º¹ ÈÄ ½±°Ô È­Àå½ÇÀ» »ç¿ëÇÒ ¼ö ÀÖÁö¸¸, ÀåÀ» Áï½Ã ÀçÁ¢ÇÕÇÒ ¼ö ¾ø°Å³ª ¼ÒÈ­°üÀÇ ´ëºÎºÐÀ» ÀýÁ¦ÇØ¾ß ÇÏ´Â °æ¿ì ÀϽÃÀû ¶Ç´Â ¿µ±¸ÀûÀÎ ½ºÅ丶/¿À½ºÅä¹Ì Äɾ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, »ê¾÷ ±¸Á¶, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ ºÐ¼®, »ç·Ê ¿¬±¸, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÇÁ·ÎÁ§Æ® ¹üÀ§¿Í Á¤ÀÇ

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • Á¦Ç°º°
    • ¿À½ºÅä¹Ì ÄÉ¾î ¹é
    • ¿À½ºÅä¹Ì ÄÉ¾î ºÎ¼Óǰ
  • ¼ö¼ú À¯Çüº°
    • ¿ä·ÎÁ¶·ç¼ú
    • ȸÀåÁ¶·ç¼ú
    • °áÀåÁ¶·ç¼ú
  • ¿ëµµº°
    • ¾Ï
    • ¿Ü»ó¡¤°¨¿°Áõ
    • ÀåÆó»öÁõ
    • ¿°Áõ¼º ÀåÁúȯ
    • ±âŸ
  • ÃÖÁ¾»ç¿ëÀÚº°
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð
    • ÀçÅà Äɾî
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ³²¹Ì
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ±â¾÷º° ½ÃÀå Á¡À¯À²

Á¦5Àå ¼¼°èÀÇ ½ºÅ丶/¿À½ºÅä¹Ì ÄÉ¾î ½ÃÀå Àü¸Á : Áö¿ªº°

  • ºÏ¹Ì
  • À¯·´
  • ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦6Àå ½ÃÀå ¸ÅÇÎ

  • Á¦Ç°º°
  • ¼ö¼ú À¯Çüº°
  • ¿ëµµº°
  • ÃÖÁ¾»ç¿ëÀÚº°
  • Áö¿ªº°

Á¦7Àå °Å½ÃÀû ȯ°æ°ú »ê¾÷ ±¸Á¶

  • ¼ö±Þ ºÐ¼®
  • ¼öÃâÀÔ ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTEL ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ÀúÇØ¿äÀÎ(°úÁ¦¡¤¾ïÁ¦¿äÀÎ)

Á¦9Àå ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í Çõ½Å

  • ƯÇã »óȲ
  • ±ÔÁ¦ ´ç±¹ ½ÂÀÎ
  • Çõ½Å/½Å±â¼ú

Á¦10Àå ÁÖ¿ä ±â¾÷ »óȲ

  • ½ÃÀå ¸®´õ »óÀ§ 5°³»ç °æÀï ¸ÅÆ®¸¯½º
  • ½ÃÀå ¸®´õ »óÀ§ 5°³»ç ½ÃÀå ¸ÅÃ⠺м®
  • M&A¡¤ÇÕÀÛÅõÀÚ(ÇØ´çµÇ´Â °æ¿ì)
  • SWOT ºÐ¼®(ÁÖ¿ä ±â¾÷)
  • ƯÇ㠺м®(ÇØ´çµÇ´Â °æ¿ì)

Á¦11Àå °¡°Ý ºÐ¼®

Á¦12Àå »ç·Ê ¿¬±¸

Á¦13Àå ÁÖ¿ä ±â¾÷ Àü¸Á

  • Coloplast Corp
  • Hollister Inc.
  • M Company
  • B. Braun Melsungen AG
  • Marlen Manufacturing & Development Co.
  • Welland Medical Limited
  • Flexicare Group Limited
  • ConvaTec Inc.
  • Smith & Nephew plc
  • Perma-Type Company Inc.

Á¦14Àå Àü·«Àû Á¦¾È

Á¦15Àå ´ç»ç ¼Ò°³¿Í ¸éÃ¥»çÇ×

ksm 24.03.25

Global stoma/ostomy care market is projected to witness a CAGR of 4.76% during the forecast period 2024-2031F, growing from USD 3.41 billion in 2023 to USD 4.95 billion in 2031F. The market expansion is supported by novel product launches, advancements in ostomy devices, a growing target patient population, and increasing patient education campaigns in various regions across the globe. The growth of geriatric population is bolstering the demand for stoma/ ostomy care products.

The market growth is supported by the increasing prevalence of various gastrointestinal diseases including inflammatory bowel disease. The increase in cases of gastrointestinal diseases can be attributed to not getting enough exercise and rising uptake of low fiber diets. According to an article published in J Clin Med, the prevalence of inflammatory bowel disease was 200 per 100,000 population in 2006 and 321.2 per 100,000 population in 2021, witnessing an increase at the rate of more than 46%. The growth of the market is further being aided by technological enhancements in the development of ostomy care bags and ostomy care accessories such as development of well-designed and effective accessories and pouching products to prevent leakages. Infections, injuries, and chronic health problems including colorectal cancer are bolstering the stoma/ostomy care market demand.

The increasing accessibility to stoma care products is another major factor supporting the market expansion. Several e-commerce platforms and reputed online pharmacies sell products and accessories essential for effective management of stoma. These platforms ensure fast delivery of the products while offering lucrative discounts to the customers.

Increasing Prevalence of Colorectal Cancer

Increasing instances of colorectal cancer in various regions across the globe is anticipated to support the stoma/ostomy care market growth. According to the American Cancer Society, in 2024 the estimated number of new cases of colon cancer in the United States is 54,210 in men and 52,380 in women and for rectal cancer is 27,330 in men and 18,890 in women. Due to the increasing cases of colorectal cancer, the requirement for stoma/ostomy care is increasing, especially in the cases of bedridden patients. In most cases the patients can use restrooms with ease after the recovery from the surgery is complete, however, if the bowel cannot be immediately reattached or if a large portion of the digestive tract had to be removed, temporary or permanent stoma/ostomy care might be required by the patient.

Increasing Investments in Research and Development Activities Expected to Support Market Growth

Rising investments in research and development activities are expected to offer lucrative growth opportunities to the market over the forecast period. In 2023, Eakin Healthcare, one of the leading suppliers and manufacturers of products and accessories related to respiratory and surgical therapies and ostomy announced an investment of EUR 19 million in research and development for establishing an Ostomy Centre of Excellence. The investment is expected to enable the company to add pilot lines including next-generation ostomy pouches and skin-friendly medical adhesives. The company has specialized in the manufacture of wound and ostomy care products since its establishment.

North America Accounts for Significant Market Share

The presence of a well-established healthcare infrastructure and major market players coupled with increasing prevalence of colorectal cancer in the region is supporting the market expansion. According to American Cancer Society, colorectal cancer is the fourth leading cause of cancer related deaths in women and third in men in the United States. The increase in aging population and growing consciousness about stoma surgeries and ostomy care among the general population is further supporting the growth of North America stoma/ostomy care market.

Meanwhile, the market in Asia-Pacific is expected to witness significant expansion over the forecast period. The growth can be attributed to the growing geriatric population and increased development of gastrointestinal diseases that require ostomy procedures. The rate of colorectal cancer appears to be steadily increasing in different parts of Asia in recent decades.

Ostomy Care Bags Account for Significant Market Share

The increasing efforts of various leading market players and startups towards the development of ostomy bags that enhance comfort while protecting against leakage are supporting the segment growth. For instance, Odapt, a Spanish start-up, developed a 3D printed solution for reducing waste and improving the usage of stoma bags. The ostomy bags designed by the startup have been designed to avoid leaks with the help of 3D printed silicone wafers. They can further eliminate the problems associated with leakages by personalizing the shape of the wafer to that of a stoma. The 3D printed silicone wafers address the different issues related to skin irritation, customization, proper fit, enhancement of aesthetic appeal, and comfort. Silicon offers biocompatibility, flexibility, softness, water resistance, transparency, color variability, and durability, making it the most suitable material for such applications. The innovative product is expected to play a pivotal role in enhancing the quality of life of the patient by ensuring the provision of tailored solutions.

Home Healthcare is Expected to Account for Significant Market Share

The increasing popularity of home healthcare is due to various advantages offered by the system including cost efficiency, comfort for patient, and growing availability of both long and short-term treatment options, supporting the stoma/ostomy care market expansion. As per the US Bureau of Labor Statistics, employment in the home healthcare sector is expected to grow by 21%. The increased preference for home healthcare can be attributed to reduced healthcare fragmentation, limited capacity of healthcare facilities, and increasing aging population.

Furthermore, due to the relatively private nature of ostomy care, several patients prefer to receive treatment and management of their condition in the privacy of their homes, in a comfortable environment. Ostomy care requires the collection of waste by the healthcare professional/caregiver and periodic cleaning. Patients are required to ensure that the pouch remains attached to their skin and protect the wound from waste. At homes, patients can receive treatment and care that are central to them, resulting in improved patient recovery.

Future Market Scenario (2024 - 2031F)

Different studies are being conducted by various research institutions for enhancing the self-sufficiency and quality of life of individuals with stoma along with the determination of the effect of stoma care training provided by various methods. For instance, Necmettin Erbakan University, Konya, Turkey is conducting a randomized controlled interventional trial to determine the effects of stoma care treatment provided by Pecha Kucha method. The inclusion criteria for the study require that the patient with stoma the first time, can understand and speak Turkish, is literate, and volunteers to participate in the study.

Key Players Landscape and Outlook

Key participants in stoma/ostomy care market are Coloplast Corp, Hollister Inc., 3M Company, B. Braun Melsungen AG, and Marlen Manufacturing & Development Co. Strategic collaborations between the key market players, increasing research and development activities, and introduction of novel technologies are expected to offer lucrative growth opportunities to the market.

In 2022, Coloplast Corp launched SenSura Mio in Singapore for stoma care. The product range offers compatible fit for different body profiles of people with stoma including outward, regular, and inward. It features a flexible fit to support movement and secure body contact for providing protection along with a discreet pouching solution.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Stoma/Ostomy Care Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Ostomy Care Bags
    • 4.2.2.Ostomy Care Accessories
  • 4.3.By Surgery Type
    • 4.3.1.Urostomy
    • 4.3.2.Ileostomy
    • 4.3.3.Colostomy
  • 4.4.By Application
    • 4.4.1.Cancer
    • 4.4.2.Trauma and Infection
    • 4.4.3.Bowel Obstruction
    • 4.4.4.Inflammatory Bowel Disease
    • 4.4.5.Others
  • 4.5.By End-user
    • 4.5.1.Hospitals
    • 4.5.2.Specialty Clinics
    • 4.5.3.Home Care
    • 4.5.4.Ambulatory Surgical Center
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.South America
    • 4.6.3.Europe
    • 4.6.4.Asia-Pacific
    • 4.6.5.Middle East & Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Stoma/Ostomy Care Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Ostomy Care Bags
      • 5.1.2.2.Ostomy Care Accessories
    • 5.1.3.By Surgery Type
      • 5.1.3.1.Urostomy
      • 5.1.3.2.Ileostomy
      • 5.1.3.3.Colostomy
    • 5.1.4.By Application
      • 5.1.4.1.Cancer
      • 5.1.4.2.Trauma and Infection
      • 5.1.4.3.Bowel Obstruction
      • 5.1.4.4.Inflammatory Bowel Disease
      • 5.1.4.5.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Hospitals
      • 5.1.5.2.Specialty Clinics
      • 5.1.5.3.Home Care
      • 5.1.5.4.Ambulatory Surgical Center
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Product
      • 5.1.6.2.1.Ostomy Care Bags
      • 5.1.6.2.2.Ostomy Care Accessories
      • 5.1.6.3.By Surgery Type
      • 5.1.6.3.1.Urostomy
      • 5.1.6.3.2.Ileostomy
      • 5.1.6.3.3.Colostomy
      • 5.1.6.4.By Application
      • 5.1.6.4.1.Cancer
      • 5.1.6.4.2.Trauma and Infection
      • 5.1.6.4.3.Bowel Obstruction
      • 5.1.6.4.4.Inflammatory Bowel Disease
      • 5.1.6.4.5.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Hospitals
      • 5.1.6.5.2.Specialty Clinics
      • 5.1.6.5.3.Home Care
      • 5.1.6.5.4.Ambulatory Surgical Center
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Surgery Type
  • 6.3.By Application
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Coloplast Corp
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Hollister Inc.
  • 13.3.3M Company
  • 13.4.B. Braun Melsungen AG
  • 13.5.Marlen Manufacturing & Development Co.
  • 13.6.Welland Medical Limited
  • 13.7.Flexicare Group Limited
  • 13.8.ConvaTec Inc.
  • 13.9.Smith & Nephew plc
  • 13.10.Perma-Type Company Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦